All News | FDA

Advertising & Promotion

Feb 23, 2018
Philadelphia Sues Opioid Makers Under Pa. Unfair Practices, Consumer Protection Laws
Feb 22, 2018
Anti-aging Supplement Maker Settles with FTC
Feb 22, 2018
OPDP’s First Untitled Letter of 2018 Hits Opioid Manufacturer’s Exhibit Booth for Minimizing Risks
Feb 20, 2018
Senate Bill Requires Controlled Substance TV Ad Review Prior To Airing
Feb 17, 2018
Ky. Supreme Court Allows Drug Advertising Case To Continue
Feb 14, 2018
Senate Report Details Pain Advocacy Groups’ Financial Connection to Opioid Manufacturers
Feb 13, 2018
U.S. Files Complaint Against Supply Company Alleging Kickbacks To Physicians
Feb 13, 2018
Purdue Stops Marketing Opioids to Prescribers
Feb 9, 2018
Bill Requiring Cost Reporting Introduced in Oregon
Feb 8, 2018
Alabama Sues Purdue Over Opioid Marketing

Good Clinical Practice

Jun 23, 2018
Questions Abound Over Returning Individual Research Results
Jun 23, 2018
FDA Sets Public Docket on Data Standards
Jun 22, 2018
OCR Releases HIPAA Guidance Mandated by Cures Act
Jun 22, 2018
Recommendations Developed for Expanding Lung Cancer Trial Eligibility Criteria
Jun 21, 2018
ClinicalTrials.gov Details Issues To Consider in Using Database
Jun 20, 2018
Revised Draft Guidance on Humanitarian Device Exemptions Incorporates Changes Under Cures Act, FDARA
Jun 19, 2018
Revised Common Rule Implementation Pushed Back to January 2019
Jun 18, 2018
Group Calls for Alzheimer’s Research To More Fully Examine Sex and Gender Differences
Jun 16, 2018
NIH To End Controversial Alcohol Study
Jun 16, 2018
ACRP to Develop CRC Hiring Guidelines

U.S. Food Labeling

FDA Regulation & Enforcement

Apr 1, 2021
Consumer Groups Want FDA To Act Quickly Against ‘Fortified’ Beer
Mar 31, 2021
Free Drug Program Would Not Lead to Sanctions, HHS OIG Concludes in First Advisory Opinion of 2021
Mar 31, 2021
Boston Scientific Settles with States Over Marketing of Surgical Mesh Devices
Mar 25, 2021
N.Y. Dietary Supplement Firm Is Shut Down After Court Modifies DOJ’s Proposed Injunction Order
Mar 24, 2021
Court Declines To Dismiss on Preemption Grounds State Law Claims Involving a PMA Cardiac Device
Mar 24, 2021
Fresenius Kabi Oncology Sentenced To Pay $50 Million for Concealing, Destroying Records Before FDA Inspection
Mar 21, 2021
OPDP Researchers Move Ahead with Proprietary Name Study
Mar 17, 2021
Criminal Charges Brought Against Supplement Firm and its Operator for Allegedly Refusing FDA Inspections
Mar 17, 2021
Senate Unanimously Passes Bill To Add Sesame to List of Major Allergens
Mar 15, 2021
OPDP Issues First Untitled Letter of 2021

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.